- Lobbying
- novartis
Lobbying Arrangements Results for 'Novartis'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details |
NOVARTIS VACCINES AND DIAGNOSTICS, INC.
|
COVINGTON & BURLING LLP | |||
Details Medical innovation, gene therapy, health care costs Gene therapy innovation State Medicaid system, innovation, Value Based Arrangements |
Novartis
|
THE WATTS GROUP PLLC | |||
Details None |
Novartis
|
Ruder Finn, In.c | |||
Details Australian government policy on intellectual property and its impact on the Australian healthcare system |
Novartis Pharmaceuticals Pty Ltd ( Australia)
|
CapitalHill Advisory | |||
Details Vaccine legislation |
NOVARTIS VACCINES AND DIAGNOSTICS, INC.
|
FOLEY HOAG LLP | |||
Details Issues related to coverage and reimbursement of pharmaceuticals. Issues related to coverage and reimbursement of pharmaceuticals |
Novartis Corporation
|
SCULLY ROSKEY AND MISSMAR | |||
Details General Healthcare Issues |
Novartis
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Environmental clean-up and management |
Novartis Pharmaceuticals, Inc.
Pharmaceuticals |
ML STRATEGIES, LLC | |||
Details HEALTHCARE |
NOVARTIS CORPORATION
HEALTHCARE |
McAllister & Quinn LLC | |||
Details Healthcare |
Novartis Vaccines and Diagnostics, Inc
|
Trimpa Group LLC | |||
Details Opportunities for health care collaboration Issues related to Medicare and Medicaid for Veterans |
Brownstein Hyatt Farber Schreck obo Novartis
|
TGB STRATEGIES LLC | |||
Details Legislation relating to influenza vaccine; pandemic planning; and general vaccine-related proposals |
Novartis Vaccines & Diagnostics Inc.
Research, manufacturing and sale of biotechnology products to improve human health |
The Duberstein Group Inc. | |||
Details Menococcal meningitis vaccine approval. |
Novartis Vaccines
|
AUX Initiatives, LLC | |||
Details Drug legislation; BioTerrorism Reauthorization |
Novartis Vaccines and Diagnostics, Inc.
Vaccines and Diagnostics Manufacturer |
Covington & Burling | |||
Details H.R.6, 21st Century Cures Act. S.2041, Promoting Life-Saving New Therapies for Neonates Act of 2015. H.R.3618, Orphan Drug Fairness Act. P.L.114-113, Consolidated Appropriations Act, 2016. Healthca... |
Novartis Services, Inc.
|
Rampy Northrup LLC | |||
Details Labor, Health and Human Services, Education and Related Agencies Appropriations Bill, Supplemental Appropriations Bill, Bioterrorism, FDA enforcement, and DoD Appropriations. |
Novartis Vaccines and Diagnostics, Inc.
Manufacturer of vaccines and blood diagnostic products. |
PARRY, ROMANI, DECONCINI & SYMMS | |||
Details REgulatory and legislative advice covering Medicare and Medicaid and other health policy issues. |
Novartis Corporation
|
LAW OFFICES OF FREDERICK H. GRAEFE, PLLC | |||
Details Pharmaceutical coverage and access in Parts A, B, C, and D. S. 2543, the Prescription Drug Pricing Reduction Act and H.R. 3, the Lower Drug Costs Now Act. Advocacy regarding access to 340B reimburs... |
Novartis
|
THE MCMANUS GROUP | |||
Details Support increased funding for the CDC National Immunization Program (sec 317 program) |
Novartis
|
Cornerstone Government Affairs, LLC | |||
Details Seek enactment of the Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2017 or similar legislation. |
Novartis Corporation
|
Barnes & Thornburg, LLP | |||
Details Issues related to drug policy, including reimbursement. |
Novartis Corporation
|
ALSTON & BIRD LLP | |||
Details Vaccine issues, other issues related to Health Care. LHHS Appropriations, Agriculture Appropriations, Vaccine issues, other issues related to Health Care. |
Novartis Corporation
|
Ice Miller Strategies LLC | |||
Details General healthcare, pharmaceutical and Food and Drug Administration (FDA) related issues. S.2041, Promoting Life-Saving New Therapies for Neonates Act of 2015; neonatal drug issues. H.R.3618, Orpha... |
Novartis Services, Inc.
|
Ogilvy Government Relations | |||
Details The Federal, Food, Drug and Cosmetic Act The Prescription Drug User Fee Act (PDUFA) Patient Protection and Affordable Care Act Biologics Price Competition and Innovation Act Protecting Consumer Acc... |
Novartis
Pharmaceutical Company |
Roberti White, LLC | |||
Details Track and trace technologies for safe medicines |
NOVARTIS
|
CROWELL & MORING INTERNATIONAL, LTD. | |||
Details Medicare reimbursement for laboratory tests. |
Physician Fee Schedule Pathology Payment Coalition
|
McDermott+Consulting LLC | |||
Details Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872) American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213) |
NOVARTIS
|
FOLEY HOAG LLP | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); S. 476 - Maintaining Investments in New Innovation Act. Is... |
Novartis
|
Tiber Creek Health Strategies, Inc. | |||
Details Tax policy - HR 4853, Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010. Vaccine policy - Executive Branch action re this issue. |
Novartis Corporation
|
THE DUBERSTEIN GROUP, INC. | |||
Details S. 476 and H.R. 5547 - Maintaining Investments in New Innovation Act. Pricing and reimbursement issues related to the Inflation Reduction Act. |
Novartis
|
RESOLUTION PUBLIC AFFAIRS, LLC | |||
Details Issues related to the importance of vaccines |
Novartis Corporation
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee program and the Me... |
Novartis
|
Ferguson Strategies, LLC | |||
Details Legislation relating to influenza vaccine; pandemic planning; and general vaccine-related proposals |
Novartis Vaccines & Diagnostics Inc. (FORMERLY Chiron Corporation)
Research, manufacturing and sale of biotechnology products to improve human health |
The Duberstein Group Inc. | |||
Details Prescription Drug User Fees, Drug Safety Issues, Pediatric Drug Issues, Drug Compounding, Direct-to-Consumer Advertising Issues Drug Regulations, Clinical Trials Issues, Vaccine Issues, Pediatric m... |
Novartis Vaccines and Diagnostics, Inc.
|
Keaney Consulting Inc. | |||
Details Issues affecting pharmaceuticals, particularly as related to efforts to repeal and replace the Affordable Care Act, and Medicare and Medicaid. Issues related to tax reform or tax legislation. |
Novartis Corporation
|
Capitol Counsel, LLC | |||
Details FY13 Department of Defense Appropriations Orphan drugs and tax issues PDUFA Patient Protection and Innovative Biologic Medicines Act of 2009 Implementation of health care reform Implementation and... |
Novartis
Pharmaceutical Company |
WINNING STRATEGIES WASHINGTON | |||
Details Medicare reimbursement for laboratory tests. |
Physician Fee Schedule Pathology Payment Coalition
|
MCDERMOTT WILL & EMERY LLP | |||
Details S. 1710, Labor-HHS-Education and related Agencies Appropriations Act, pandemic funding and vaccine issues HR 3043, Labor - HHS-Education and related Agencies appropriations Act, pandemic influenza ... |
Novartis Vaccines and Diagnostics, Inc.
|
in-house lobbying | |||
Details General health care coverage and reimbursement for prescription drugs; drug pricing reform, including the 340b Program; and the Food and Drug Administration legislation, include the Prescription Dr... |
Novartis
|
East End Group, LLC | |||
Details CBO modeling Drug Pricing Fiscal year 2024 Appropriations H.R. 5376, Inflation Reduction Act H.R. 6363, the Further Continuing Appropriations and Other Extensions Act, 2024 Importation Value of Med... |
NOVARTIS
|
in-house lobbying | |||
Details Global Health Issues Substandard drugs in developing world TransPacific partnership negotiations - No Specific Legislation |
Novartis Pharmaceuticals Corporation
|
BOCKORNY GROUP, INC. | |||
Details Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148). Issues related to pharmaceutical pricing and biosimilars. H.R.5376 - Inflation Reduction Act of 2022... |
Novartis Corporation
|
Thorn Run Partners | |||
Details Issues related to domestic healthcare and pricing; Issues related to cell and gene therapies; Issues related to supply chain management, Issues related to intellectual property. Issues related to o... |
Novartis
|
Monument Advocacy | |||
Details Issues related to importation of prescription drugs issues affecting pharmaceutical manufacturers in HR 3590, the Patient Protection and Affordable Care Act issues related to coverage of vaccines i... |
NOVARTIS
|
RICCHETTI INCORPORATED | |||
Details Provide guidance and strategic counsel with regard to DEA scheduling of FDA approved products. |
DEA Scheduling Coalition (Informal Coalition)
|
BGR Government Affairs | |||
Details Health care policy and reform. Medical innovation. Cancer treatments. H.R.2641 - Promoting Life-Saving New Therapies for Neonates Act of 2017. Issues related to drug pricing. S.540 - Mobile Workfor... |
Novartis Services, Inc.
|
PODESTA GROUP, INC. | |||
Details DOJ policy regarding off label communications. |
Medical Information Working Group
|
SIDLEY AUSTIN LLP | |||
Details Medicare reimbursement for laboratory tests. Issues concerning regulation of laboratory tests. |
Clinical Laboratory Fee Schedule Reform Coalition
|
MCDERMOTT WILL & EMERY LLP | |||
Details Medicare reimbursement for laboratory tests. Issues concerning regulation of laboratory tests. |
Clinical Laboratory Fee Schedule Reform Coalition
|
McDermott+Consulting LLC | |||
Details Issues related to congressional vision caucus events and eye health. Issues related to Medicare reimbursement and ASC settings. |
Novartis Corporation
|
THE NICKLES GROUP, LLC |